Translate

Tuesday, December 3, 2013

Public Health Care Bribes To Government Officials: Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe - Bloomberg

Public Health Care Bribes To Government Officials Can Be The Basis For Large Whistleblower Rewards by International Public Health Care Bribe Lawyer Jason S. Coomer

International whistleblowers can recover large amounts of money for exposing international medicine procurement kickbacks, medicine supply chain bribes, and other violations of the Foreign Corrupt Practices Act.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of international drug company bribes, international pharmaceutical company illegal kickback schemes, public health medicine procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, medication, pharmaceutical, and medical equipment contracts.

For more information on this topic and confidential reviews of Public Health Care Bribe Whistleblower Reward Lawsuits, please go to the following web page:  International Medicine Bribe Whistleblower Reward Law Center.

Each Year Approximately $1 Trillion In Public Health Care Contracts Are Obtained Through Bribes and Illegal Kickbacks

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $750 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicines, pharmaceuticals, medical equipment, and medical devices is lost to corrupt and fraudulent acts.  These acts include government official bribes, illegal kickbacks, and other illicit payment and fraud schemes.

Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe - Bloomberg

Glaxo agreed last year to pay a record $3 billion fine in the U.S. to settle allegations that the company illegally marketed medicines. That settlement came with a “Corporate Integrity Agreement” with the U.S. government that requires Glaxo to report any investigation or legal proceedings.

“Ongoing risks include the global regulatory fallout, foremost in the U.S., from any repercussions in China,” Kepler Cheuvreux’s environmental, social and governance research team said in a report on corruption in the pharmaceutical industry last month.

Anti-corruption investigations may also spill over to other countries such as India, Brazil and Russia, especially during election years, according to Kepler analyst Sudip Hazra.
“They could potentially use these precedents in the U.S. and China to embolden them politically,” Hazra said.


Saturday, November 30, 2013

International Public Health Bribes and Whistleblower Rewards: SEC Charges Pfizer with FCPA Violations | Investor.gov


International Whistleblower Reward Laws Offer Financial Rewards and Bounties to International Whistleblowers That Expose Illegal Bribes to Government Officials by Confidential International Illegal Bribe Whistleblower Lawyer Jason S. Coomer

International whistleblowers can recover large rewards for exposing international medicine procurement kickbacks, public health care bribes, and other violations of the Foreign Corrupt Practices Act.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of international bribes and illegal kickbacks are encouraged to contact an international whistleblower lawyer to have their whistleblower reward case confidentially reviewed.

For more information on a potential Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please go to the following web page on International Public Health Care Bribe Whistleblower Reward Lawsuits or use our submission form.

SEC Charges Pfizer with FCPA Violations | Investor.gov

The SEC alleges that employees and agents of Pfizer’s subsidiaries in Bulgaria, China, Croatia, Czech Republic, Italy, Kazakhstan, Russia, and Serbia made improper payments to foreign officials to obtain regulatory and formulary approvals, sales, and increased prescriptions for the company’s pharmaceutical products. They tried to conceal the bribery by improperly recording the transactions in accounting records as legitimate expenses for promotional activities, marketing, training, travel and entertainment, clinical trials, freight, conferences, and advertising.

The SEC separately charged another pharmaceutical company that Pfizer acquired a few years ago – Wyeth LLC – with its own FCPA violations. Pfizer and Wyeth agreed to separate settlements in which they will pay more than $45 million combined to settle their respective charges. In a parallel action, the Department of Justice announced that Pfizer H.C.P. Corporation agreed to pay a $15 million penalty to resolve its investigation of FCPA violations.

“Pfizer subsidiaries in several countries had bribery so entwined in their sales culture that they offered points and bonus programs to improperly reward foreign officials who proved to be their best customers,” said Kara Brockmeyer, Chief of the SEC Enforcement Division’s Foreign Corrupt Practices Act Unit. “These charges illustrate the pitfalls that exist for companies that fail to appropriately monitor potential risks in their global operations.”

According to the SEC’s complaint against Pfizer filed in U.S. District Court for the District of Columbia, the misconduct dates back as far as 2001. Employees of Pfizer’s subsidiaries authorized and made cash payments and provided other incentives to bribe government doctors to utilize Pfizer products. In China, for example, Pfizer employees invited “high-prescribing doctors” in the Chinese government to club-like meetings that included extensive recreational and entertainment activities to reward doctors’ past product sales or prescriptions. Pfizer China also created various “point programs” under which government doctors could accumulate points based on the number of Pfizer prescriptions they wrote. The points were redeemed for various gifts ranging from medical books to cell phones, tea sets, and reading glasses. In Croatia, Pfizer employees created a “bonus program” for Croatian doctors who were employed in senior positions in Croatian government health care institutions. Once a doctor agreed to use Pfizer products, a percentage of the value purchased by a doctor’s institution would be funneled back to the doctor in the form of cash, international travel, or free products.

Sunday, June 16, 2013

Foreign Corrupt Practices Act SEC Bounty Actions, Whistleblower Rewards, and Confidential Reviews by International Foreign Corrupt Practices Act Bounty Action Lawyer Jason S. Coomer

Foreign Corrupt Practices Act SEC Fraud Whistleblower Bounty Actions Are Designed to Expose Significant SEC and FCPA Violations by Offering Large Financial Rewards to People That Are The Original Source of Information That Expose Illegal Bribes, Kickbacks, and other SEC FCPA Violations by International FCPA Lawyer

SEC Fraud Whistleblower Lawsuits or SEC Bounty Actions are a product of the enactment of the Dodd-Frank Wall Street Reform and Consumer Protection Act.  These laws were designed to create bounties that can be collected by whistleblowers that properly report Foreign Corrupt Practices violations, illegal brides, kickback schemes, money laundering, SEC violations, international financial fraud, securities fraud, and commodities fraud that result in monetary sanctions over one million dollars ($1,000,000.00).  The SEC can award the whistleblower up to 30% of the money collected.

By creating whistleblower bounties for investors and people with specific information of fraud, it is expected that hard to detect fraud will be exposed to help regulate the financial market and prevent large investment corporations, banks, hedge funds, and other large corporations from committing financial fraud of billions of dollars.  Further, new whistleblower protection laws allow potential whistleblowers to confidentially report potential bounty actions through a lawyer.  These protections allow professionals to protect their identities and career while having a potential bounty action reviewed.


 International Illegal Bribery Schemes Can Be The Basis of SEC Bounty Actions

The Foreign Corrupt Practices Act (FCPA) prohibits bribery of foreign officials by U.S. and foreign companies listed on the U.S. securities exchange.  The FCPA also requires such companies to maintain accurate books and records.  Foreign Corrupt Practices Act Whistleblowers that properly report violations of the FCPA by a U.S. or foreign company listed on the U.S. securities exchanges can recover a large reward for exposing FCPA violations.


If you are aware of a significant Foreign Corrupt Practice Act  violation, please feel free to contact Foreign Corrupt Practices Act Whistleblower Reward Lawyer Jason Coomer via e-mail message or go to the following web site: International Illegal Bribery Schemes and International Whistleblower Reward Information

Monday, April 29, 2013

Foreign Corrupt Practices Act Whistleblower Rewards by Confidential Foreign Corrupt Practices Act Whistleblower Lawyer Jason S. Coomer

Foreign Corrupt Practices Act Whistleblowers Can Received Large Financial Rewards For Exposing International Bribes, Illegal Kickbacks, Slush Funds, and other Illegal Activities by International Foreign Corrupt Practices Lawyer Jason S. Coomer

The Foreign Corrupt Practices Act and the new SEC Whistleblower Incentive Program work together to reward whistleblowers with original and specialized knowledge and evidence of international business corporate bribery and illegal kickbacks.  These new international business whistleblower reward laws are part of a worldwide movement to expose and punish government corruption such as contract bribes, illegal kickbacks, and large scale international fraud.  These Foreign Corrupt Practices Act should help prevent government corruption in many countries including Russia, China, Mexico, and Brazil.

For more information on this topic, please go to the following web page:  International Business Bribery Whistleblower Reward Lawyer.

Sunday, April 28, 2013

Parker Drilling Company (Release No. LR-22672; April 16, 2013)

Parker Drilling Company (Release No. LR-22672; April 16, 2013)

SEC Charges Parker Drilling Company with Violating the Foreign Corrupt Practices Act

The Securities and Exchange Commission today charged Parker Drilling Company, a worldwide drilling services and project management firm, with violating the Foreign Corrupt Practices Act (FCPA) by authorizing improper payments to a third-party intermediary retained to assist the company in resolving customs disputes.

The SEC's complaint, filed in federal district court in Alexandria, Virginia, alleges that in 2004 Parker Drilling authorized payments to a Nigerian agent totaling $1.25 million. The company did so despite former senior executives knowing that the agent intended to use the funds to "entertain" Nigerian officials involved in resolving Parker Drilling's ongoing customs problems. Following the Nigerian agent's work, the company received an unexplained $3,050,000 reduction of a previously assessed customs fine, and the company was permitted to nationalize and sell its Nigerian rigs.

To settle the SEC's charges, Parker Drilling will pay disgorgement of $3,050,000 plus pre-judgment interest of $1,040,818. Parker Drilling consented to the entry of a final judgment permanently enjoining it from violating Sections 30A, 13(b)(2)(A), and 13(b)(2)(B) of the Exchange Act. The proposed settlement is subject to court approval.

In the parallel criminal proceedings, the Department of Justice entered into a Deferred Prosecution Agreement with Parker Drilling in which the company will pay an $11,760,000 penalty.

International Oil Company Employee Whistleblowers Can Earn Large Rewards for Exposing Fraud and Violations of SEC Laws

Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, all domestic and foreign companies registered with the U.S. Securities and Exchange Commission (SEC) must publicly report how much they pay governments for access to their oil, gas and minerals, beginning in FY2012. These payments must be reported on a country-by-country and a project-by-project basis, and will likely cover a wide range of the material benefits that accrue to governments from extractive deals.  This Dodd-Frank reporting requirement, known as the Cardin-Lugar Transparency Amendment is expected to help remove corruption from the oil and gas mineral extraction industry.

International Oil Company Bribes and other FCPA violations as well as , International Oil Company False Reports and other SEC violations are forms of fraud that can result in whistleblower bounty actions, shareholder lawsuits, and several other types of litigation.  Petroleum employees including petroleum accountants, petroleum executives, and other oil company employees with original information of significant oil company fraud, international oil lease bribes to government officials, and other illegal conduct a large oil company may be able to collect a large reward through several whistleblower laws.

The key to obtaining a large whistleblower award is to make sure that as the international oil company whistleblower you are the first to file with sufficient evidence of significant fraud.  For more information on confidentially having your case reviewed, please go to the following web page: International Oil Company Whistleblower Reward Lawsuits

Sunday, February 3, 2013

Violations of the Foreign Corrupt Practices Act (FCPA) By Sub-Suppliers and Sub-Contractors Can Be The Basis of Bounty Actions By FCPA Sub-Contractor Lawyer and FCPA Sub-Supplier Lawyer

Violations of the Foreign Corrupt Practices Act (FCPA) Including Direct and Indirect Acts By Sub-Suppliers and Sub-Contractors Can Be The Basis of Bounty Actions By FCPA Sub-Contractor Lawyer and FCPA Sub-Supplier Lawyer

Globalization of supply chains has created a shift in where many component product parts are produced.  This shift includes the production of electronic components that are used in aircraft, military weapons systems, computers, medical equipment, and other products.  In many situations, large corporations and government contractors will use sub-contractors and sub-suppliers to produce these component parts.  These large corporations and government contractors can become the basis of a Bounty Action or Whistleblower Reward Lawsuit, when these sub-contractors and sub-suppliers 1) violate the FCPA, 2) produce faulty component parts, or 3) do business with prohibited parties.  

If you are aware of Foreign Corrupt Practice Act (FCPA) violations, sub-standard components, or other supply chain fraud, please feel free to contact FCPA Sub-Contractor Bounty Action Lawyer via e-mail message  or use our submission form.  Please also feel free to go to the following web pages for more information on International FCPA Bounty Actions and Whistleblower Reward Lawsuits

Faulty Electronic Components Can Be The Basis of FCPA Bounty Actions and Whistleblower Reward Lawsuits

Many electronic components were traditionally manufactured in the United States and Europe, but are now being manufactured in China, Mexico, India, and South America.  When these electronic components are fake or substandard parts, the general government contractor can sometimes be held to have made false certifications regarding the quality of these electronic components.  These false certifications can be the basis of a Qui Tam False Claims Act Whistleblower Reward Lawsuit.  

These lawsuits encourage whistleblowers including international whistleblowers along the electronic component supply chain to blow the whistle on fake military electronic components, low quality electronic components, and other counterfeit electronic parts.

For more information on this issue, please feel free to go to the following web pages: Defense Contractor False Certification Whistleblower Reward Lawsuits, and Military Contractor Fake Part Procurement Fraud Whistleblower Lawsuits.


 FCPA Violations Can Also Be The Basis of Bounty Actions

FCPA violations in the supply chain by sub-contractors and sub-suppliers can also be the basis of Bounty Actions that offer large rewards for persons with original and specialized knowledge of the violations.  These Bounty Actions can disgorge large contracts and be the basis of substantial recoveries for the whistleblower.  Further, recent whistleblower protections now allow whistleblowers to anonymously file bounty actions through a FCPA Bounty Action Lawyer.   

For more information on this issue please feel free to go to the following web pages: FCPA Violations in Pharmaceutical Industry, FCPA Violations in the Oil Industry, FCPA Violations in the Financial Services Industry, FCPA Violations in the Electronics Industry, and



Boeing and the Conduct of Due Diligence on Sub-Suppliers « FCPA Compliance and Ethics Blog
"The Foreign Corrupt Practices Act (FCPA) act has language which makes illegal a direct or indirect act which might be used to obtain or retain business from prohibited parties. This has caused companies to begin to look at their suppliers as one area which might give them FCPA exposure."

Monday, January 21, 2013

International Drug Company Fraud Bounty Action: Rewards Are Being Offered To Professionals That Expose International Drug Company Fraud by International Drug Company Fraud Lawyer

International Drug Company Fraud Bounty Action: Rewards Are Being Offered To Professionals That Expose Illegal Kickbacks, Illegal Bribes, Slush Funds, and Fraud Committed By International Drug Companies by International Drug Company Fraud Lawyer Jason S. Coomer

Worldwide government purchasing is estimated to be over $10 Trillion each year.  Of this amount a growing percentage of government contracts are for public health care, medical equipment, and drug contracts.  Because of the vast amounts of money governments are spending on drug contracts, medical equipment contracts, and other procurement contracts, several large corporations have targeted these contracts and are using illegal bribes, kickbacks, fraud, and other illegal actions to secure these contracts.  

As such, several governments have created reward laws called bounty actions that provide large financial incentives to persons with original knowledge of these crimes to confidentially and properly expose these crimes.  By working through an international bounty action lawyer, these people include many professionals can protect their identity and career, while exposing fraud and illegal conduct.

Confidentially Exposing International Drug Company Fraud and Illegal Conduct

If you are aware of a drug contract, medical equipment contract, or other government procurement contract that is the product of fraud, an illegal bribery scheme, illegal kickback scheme, and other illicit payment scheme, it is important that you properly report the government corruption and work with an international bounty action lawyer to determine the best way to expose the corruption.

To help determine if a large government corruption scheme may be a Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please feel free to send an e-mail message to International Drug Company Fraud Bounty Action Lawyer Jason Coomer

For more information on these issues, please feel free to go to the following web pages:

Procurement Fraud International Bounty Action Lawyer

GlaxoSmithKline Agrees to Pay $3 Billion in Fraud Settlement - NYTimes.com 

"In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday. The agreement also includes civil penalties for improper marketing of a half-dozen other drugs." 

Sunday, January 20, 2013

International Money Laundering Targeted: The United States Department of Justice and Securities Exchange Commission Are Offering Large Financial Rewards For Persons That Properly Expose International Bank Fraud and Money Laundering by International Money Laundering Lawyer Jason S. Coomer

International Money Laundering Targeted:  The United States Department of Justice and Securities Exchange Commission Are Offering Large Financial Rewards For Persons That Properly Expose International Bank Fraud and Money Laundering by International Money Laundering Lawyer Jason S. Coomer

The United States Department of Justice and Securities Exchange Commission are targeting banks, financial institutes and other large corporations that are illegally laundering money.  Large international corporations that are registered with the SEC and/or are doing business in the United States may be subject to substantial fines and penalties for money laundering, bank fraud, illegal kickbacks, fraudlent accounting practices, and other illegal activities.

Further, recent Bounty Actions have been enacted to provide large financial incentives to persons with original knowledge of these illegal activities to be the first to properly confidentially report these crimes.  For more information on these Bounty Action Laws and how to confidentially report money laundering, bank fraud, illegal kickbacks, fraudlent accounting practices, or other illegal activities,  please feel free to contact International Money Laundering Bounty Action Lawyer, Jason S. Coomer.

Please also feel free to go to the following web pages:

International Hedge Fund Fraud Bounty Action Lawyer

International Financial Services and Bank Fraud Bounty Action Lawyer  

For more information on International Crack Downs on Money Laundering, please also read the following article:

HSBC to pay $1.92 billion in money-laundering settlement - Dec. 10, 2012

Global banking giant HSBC will pay $1.92 billion in a record settlement with U.S. regulators to resolve money-laundering allegations.

The Department of Justice and U.S. Treasury said Tuesday that HSBC allowed the most notorious international drug cartels to launder billions of dollars across borders. In addition, the government said HSBC violated U.S. sanctions for years by illegally conducting transactions on behalf of customers in Iran, Libya, Cuba, Sudan and Burma.